UNION CITY, Calif., April 19, 2011 /PRNewswire/ — Abaxis, Inc.
(NasdaqGS: ABAX), a medical products company manufacturing
point-of-care blood analysis systems, has scheduled a conference
call to discuss its financial results for the fourth quarter and
fiscal year 2011, ended March 31, 2011. The call will be at 4:15
p.m. ET on Thursday, April 28, 2011. The Company will report
financial results for the fourth quarter and fiscal year 2011 after
the market closes on Thursday, April 28, 2011.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
company’s website at www.abaxis.com. A replay of the
call is available by visiting www.abaxis.com for the next 30
days or by calling (877) 344-7529 or (412) 317-0088, confirmation
code 450287, through May 3, 2011.
About AbaxisAbaxis develops, manufactures, markets and sells
portable blood analysis systems for use in any veterinary or human
patient-care setting to provide clinicians with rapid blood
constituent measurements. The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The
system can be operated with minimal training and performs multiple
routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the
precision and accuracy equivalent to a clinical laboratory
Lytham Partners, LLCChief Executive Officer
Joe Dorame, Joe Diaz & Robert BlumAbaxis, Inc.